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The Nef protein of HIV-1 is capable of performing at least two functions: reduction of cell-surface expression of CD4,
the viral receptor, and enhancement of HIV-1 infectivity. Here we report the results of assays of CD4 downregulation by
nef point mutants. Areas of high charge density and highly conserved sequence motifs were targeted. In general, mutations
in the carboxyl-terminal half of the protein had more deleterious effects than did those in the amino-terminal half. A single
mutant nef allele was identified which encoded a stable protein but was completely inactive. Two mutant Nef proteins
exhibited temperature-sensitive phenotypes in assays of CD4 downregulation. q 1996 Academic Press, Inc.
INTRODUCTION altering the processing of the internalized viral core, ren-
dering it more competent for viral DNA synthesis.
Unique to primate lentiviruses, the nef gene was first
In addition to its effects on the virus itself, nef expres-reported to inhibit HIV-1 replication in culture by acting
sion in the infected cell leads to the rapid downregulationas a negative regulator of viral gene expression (Ahmad
of cell-surface CD4 expression (Aiken et al., 1994; Garciaand Venkatesan, 1988; Luciw et al., 1987; Niederman
and Miller, 1991; Guy et al., 1987). Nef accomplishes thiset al., 1989). Subsequent reports failed to confirm this
by triggering the rapid internalization of CD4, resulting(Hammes et al., 1989; Kim et al., 1989); instead, Nef was
in its degradation in lysosomes (Aiken et al., 1994; Rheefound to be crucial for efficient SIV replication and patho-
and Marsh, 1994). The membrane-proximal portion ofgenesis in rhesus monkeys (Kestler et al., 1991) and for
the cytoplasmic domain of CD4 is both necessary andHIV-1 replication in the SCID/hu mouse model (Jamieson
sufficient for downregulation by Nef (Aiken et al., 1994;et al., 1994). Furthermore, Nef enhances virus replication
Anderson et al., 1994). Although Nef-accelerated CD4in culture. This has been shown both in primary human
endocytosis is accompanied by the dissociation of thelymphocytes and macrophages (de Ronde et al., 1992;
tyrosine kinase p56lck from CD4 (Aiken et al., 1994; RheeMiller et al., 1994; Spina et al., 1994) and in established
and Marsh, 1994), downregulation of CD4 by Nef is alsoT-cell lines (Terwilliger et al., 1991; Chowers et al., 1994).
observed in cells devoid of Lck (Aiken et al., 1994; GarciaRecently a significant infectivity enhancement by HIV-1
and Miller, 1991). Furthermore, altered CD4 moleculesNef has been observed in single-round assays using
incapable of binding Lck are also sensitive to Nef. There-CD4-expressing Hela cells containing a Tat-responsive
fore, Nef does not appear to act specifically through Lck.lacZ gene (Miller et al., 1994). We and others have re-
Although direct binding of CD4 by Nef has been reportedcently investigated the molecular basis of this phenome-
by one group (Harris and Neil, 1994), this result awaitsnon (Aiken and Trono, 1995; Chowers et al., 1995;
confirmation, and the details of the mechanism of CD4Schwartz et al., 1995). Although the positive influence of
downregulation by Nef remain to be elucidated.Nef on HIV infectivity is determined at the stage of viral
Of interest is the relationship between Nef-mediatedparticle formation, the consequences of Nef action are
CD4 downregulation and enhancement of HIV infectivity.manifested only after the virus enters target cells: specifi-
Both effects are induced by a great number of nef alleles,cally, nef-defective viruses are internalized normally but
including ones cloned from primary HIV-1 isolates (Mari-do not efficiently reverse transcribe the viral RNA. Since
ani and Skowronski, 1993; Aiken and Trono, 1995). Never-Nef apparently affects neither the genomic RNA content
theless, recent findings suggest that the two activities ofnor the reverse transcriptase activity of HIV-1 virions,
Nef might be independent of one another. First, wild-typethese results suggest that the viral protein might act by
and nef-defective viruses produced in the absence of
CD4 retain their infectivity difference (Aiken and Trono,
1 Present address: Department of Microbiology and Immunology,
1995; Miller et al., 1994, 1995). In addition, enhancementVanderbilt University School of Medicine, Nashville, TN 37232.
of virus infectivity is not related to CD4 downregulation2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (619) 453 7760; E-mail: trono@sc2.salk.edu. by Nef in the infected cell, since the infectivity difference
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is also observed using CD40 target cells or cells express- try 2 days after transfection, and two-dimensional con-
tour plots were prepared on a Sun workstation usinging a truncated CD4 molecule unable to respond to Nef
(Aiken and Trono, 1995; Chowers et al., 1995). Further- Sundisplay 3 software. Propidium iodide was included
for live-cell discrimination. Surface CD8 expression wasmore, mutations in a conserved proline-repeat motif
markedly impaired the ability of Nef to stimulate virus used as a marker for transfected cells, since surface
levels of the CD884LL414AA chimera are not affected byreplication in primary PBMC infected prior to activation
(Saksela et al., 1995) and to enhance HIV-1 infectivity in Nef (Aiken et al., 1994). Regions were drawn such that
the two right-hand quadrants contained only CD8/ cells,a single cycle of infection (Goldsmith et al., 1995). How-
ever, these mutations did not inhibit CD4 downregulation representing the cells that were transfected. Transfec-
tion efficiencies measured in this way were typicallyby Nef, indicating that the two activities of Nef can be
genetically dissected. 50% or higher and were not significantly different in the
presence or absence of Nef. Nef activity was calculatedIn order to identify additional regions of the Nef protein
required for its functions, we undertook a mutational by measuring the ratio of the fraction of CD4-negative
cells (lower right quadrant) to CD4-positive cells (upperanalysis of Nef. Alterations of conserved amino acids
and clusters of high charge density were assessed for right quadrant) for the transfection with CMX.nef1 and
dividing it by the corresponding ratio for the controltheir effects on CD4 downregulation. In general, muta-
tions in the carboxyl-terminal half of the protein had more transfection lacking Nef. In practice it was convenient
to draw the quadrants so that the control transfectiondeleterious effects than did those in the amino-terminal
half. A single mutant allele was found to produce a stable had the same number of CD4/ and CD40 cells, thereby
simplifying the calculations. We found that the calcu-protein that was inactive. Finally, two mutant alleles ex-
hibited temperature-dependent CD4 downregulation ac- lated values were not affected by small variations in
how the quadrants were drawn. The activity of eachtivity.
mutant nef construct was determined as a percentage
of the fold CD4 downregulation by wild-type Nef, whichMATERIALS AND METHODS
ranged from 4- to 12-fold between experiments. Within
DNA constructs a given experiment, CD4 downregulation by wild-type
Nef varied by approximately 10%.Mutations in the nef coding sequence were created by
oligonucleotide mismatch-directed mutagenesis in M13
Western blotting analysis(Kunkel, 1985), and mutant nef genes were transferred
into the pCMX expression plasmid (Umesono et al., Transfected 293 cells were lysed in a buffer of 100
1991). Alternatively, PCR fusion was used to create the mM Tris–HCl, pH 7.5, 100 mM NaCl, and 0.5% NP-40
desired mutation directly in the nef expression vector (cell lysis buffer). Nuclei were pelleted by centrifugation
itself. Candidates were screened by restriction analysis (14,000 g for 5 min), and the supernatants were assayed
and mutations were verified by DNA sequencing. by the BCA protein microassay (Pierce). Aliquots con-
taining 100 mg of protein were subjected to electrophore-
Antibodies sis on 12.5% polyacrylamide gels containing SDS. The
proteins were electroblotted onto PVDF membranesR-phycoerythrin-conjugated anti-human CD4 and
(PVDF-Plus; MSI Corp.) and blocked overnight inFITC-conjugated anti-human CD8 were purchased from
TBST/5% nonfat dry milk after staining with Ponceau SDAKO (Carpinteria, CA) and were used at a 1:20 dilution
to confirm equivalent protein loading. Blots were probedto stain cells for flow cytometry. Rabbit anti-Nef serum
with serum from a rabbit immunized with Nef proteinwas produced by immunization of New Zealand White
produced in E. coli and were developed using chemilumi-rabbits with recombinant HXB2 Nef produced in Esche-
nescent detection (ECL; Amersham Corp.).richia coli and was used at 1:2000 for Western blotting
and 1:500 for immunoprecipitation.
Pulse–chase assays of Nef stability
CD4 downregulation assay
Two days after transfection, 293 cells were pulsed-
labeled at 377 for 30 min with 0.5 mCi Tran35S-Label (ICNTransient assays for CD4 downregulation were per-
formed in 293 cells as described (Aiken et al., 1994). A Biomedicals) in 2.5 ml of cysteine- and methionine-free
medium. After removing the labeling medium, the cellsNef-resistant CD8 – CD4 chimera, 884LL414AA, which con-
tains the extracellular and transmembrane domains of were suspended in complete medium and incubated at
the indicated temperatures. Aliquots were removed atCD8 fused to a dileucine-mutated CD4 cytoplasmic do-
main, served as control. Briefly, 10 mg each of pCMX- various times, and the cells were washed once in ice-
cold phosphate-buffered saline and lysed in cell lysisCD4 and pCMX-CD884LL414AA were transfected with 20
mg of CMX.nef1 or a control vector. Cells were analyzed buffer. Samples of the lysates containing 200 mg of pro-
tein were subjected to immunoprecipitation using rabbitfor surface marker expression by two-color flow cytome-
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Levels of expression of the various Nef mutants were
assessed by Western blotting of cytoplasmic lysates of
transfected 293 cells and detection with a rabbit poly-
clonal antiserum against recombinant Nef (Fig. 2A). Fur-
thermore, all variants whose steady-state levels ap-
peared decreased by this technique were further evalu-
ated through a pulse–chase analysis (Fig. 2B). Twelve
of seventeen charge-to-alanine mutants in nef produced
stable proteins upon transfection into 293 cells, as deter-
mined by Western blotting. Exceptions included D108A/
D111A, K158A/E160A, and ERE179AAA (Fig. 2A, lanes 10, 12,
and 23). Pulse–chase analysis demonstrated that the
D108A/D111A and ERE179AAA proteins were synthesized at
normal levels but were significantly less stable than wild-
type Nef (Fig. 2B). In contrast, the K158A/E160A protein
FIG. 1. Sequence of Nef protein and mutations generated in this
study. Mutant nef alleles were generated by the Kunkel method, or by
using the polymerase chain reaction, and cloned into pCMX, a CMV
promoter-based eukaryotic expression plasmed.
anti-Nef serum and protein A–agarose (Santa Cruz Bio-
technology), and immunoprecipitates were analyzed by
electrophoresis on 12.5% polyacrylamide gels containing
SDS. Gels were soaked in Fluoro-Hance (Research Prod-
ucts International), dried under vacuum, and exposed to
X-ray film.
RESULTS
Nef mutagenesis
In order to determine what regions of Nef are required
for its ability to downregulate surface CD4 expression,
point mutations in the nef coding sequence were created
in regions containing a high density of charged residues.
This mutagenesis strategy is based on the rationale that
regions of high charge density are likely to be present
FIG. 2. Expression levels of the various Nef point mutants used in this
on the surface of the protein and may interact with other study. (A) Western blotting analyses were performed with cytoplasmic
proteins (Gibbs and Zoller, 1991). Also, because clusters lysates of transfected 293 cells. Normalized amounts of protein (50–
100 mg) were analyzed by electrophoresis on denaturing 15% polyacryl-of charged amino acids have a lower probability of being
amide gels containing SDS. Proteins were transferred to PVDF mem-on the inside of the folded protein, alteration of these
branes, which were probed with a rabbit polyclonal antiserum directedresidues is unlikely to interfere with the general structure
against recombinant Nef protein. Nef proteins were visualized using
of the polypeptide. Except for doublets of glutamic acid the ECL chemiluminscent detection system. (B) Pulse–chase analysis
codons which were mutated to glutamines, the charged of Nef stability in transfected 293 cells. Cells were transfected with
nef-expression constructs and pulse-labeled for 30 min using [35S]-residues were converted to alanines (Fig. 1). In addition,
methionine and cysteine as described under Materials and Methods.amino acids that are highly conserved among nef iso-
Samples of the cultures were harvested at the indicated times andlates (Shugars et al., 1993), including threonine 80 (repre-
lysates were subjected to immunoprecipitation using a rabbit poly-
senting a potential phosphorylation site), two cysteine clonal anti-Nef antiserum. Labeled bands were visualized by autoradi-
residues, and a proline-repeat sequence [the so-called ography after electrophoresis on 12.5% polyacrylamide gels containing
SDS.(Pxx)4 motif] were also targeted (Fig. 1).
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exhibited no apparent decrease in stability (Fig. 5B). The to be essentially unimpaired for activity. On the other
hand, values for functionally impaired Nef mutants exhib-mutant Nef proteins EE155QQ and E201A/K204A were also
weakly detected by Western blotting (Fig. 2A, lanes 22 ited lower standard deviations. Most of the substitutions
in the amino-terminal half of Nef did not drastically impairand 14), but exhibited similar stabilities as wild-type Nef
in pulse–chase assays (Fig. 2B). Of mutations targeting CD4 downregulation by Nef in transfected 293 cells. The
exceptions were the double-alanine substitution at posi-other conserved motifs, T80A and C142A also exhibited
low steady-state levels (Fig. 2A, lanes 8 and 11). Thr80 tions 35 and 36 and the substitution of alanine for threo-
nine at position 80. Mutation of Arg35 and Asp36 to ala-represents a consensus phosphate acceptor target for
protein kinase C, and substitution of alanine at this posi- nines resulted in production of a stable protein which
was 21% as active as wild-type Nef. As discussed pre-tion rendered Nef unstable (Fig. 2B). Thus it is possible
that phosphorylation of this residue is required for Nef viously, mutation of Thr80, a putative protein kinase C
target, resulted in a protein which was poorly detectedstability. Mutation of Cys142 to alanine also reduced the
half-life of the protein (Fig. 2B), consistent with the hy- in Western blots and was significantly less stable than
wild-type Nef. Nevertheless, this mutant exhibited levelspothesis that this cysteine may be required for the proper
folding of Nef. This mutation has been reported to de- of activity (11% of wild-type Nef) roughly proportional to
its steady-state expression levels. Alteration of Cys55crease the stability of the Eli Nef protein (Zazopoulos
and Hazeltine, 1992). Alteration of the four conserved to Ala resulted in a 28% decrease in activity. Pairwise
elimination of the four glutamic acid residues in the con-proline codons at positions 69, 72, 75, and 78 resulted
in expression of a stable protein (Fig. 2A, lane 27). served acidic block (aa 62–65) did not impair the activity
of Nef. Interestingly, a deletion spanning residues 60–
Assay of Nef-dependent CD4 downregulation 71 was previously reported to effectively eliminate Nef
activity (Goldsmith et al., 1995). Our results suggest that
In order to measure CD4 downregulation by mutant
elements in this region other than the four Glu residues
Nef proteins, a transient transfection assay was em-
may be critical for Nef function or that two acidic residues
ployed which was previously developed to map the re-
may suffice. Mutation of the four proline residues in the
gion of CD4 that is responsive to Nef (Aiken et al., 1994).
conserved (Pxx)4 motif (aa 69–78) to alanines reducedA CD4 expression plasmid was transfected into 293 cells
CD4 downregulation activity to 43% of wild-type Nef. Pair-
together with vectors expressing the Nef variants. In
wise mutation of these four residues had similar effects.
these assays, a plasmid encoding a chimeric protein,
Mutations in the C-terminal half of the protein generally
consisting of the extracellular and transmembrane do-
were more detrimental to Nef function. Alteration of a
mains of CD8 fused to a CD4 cytoplasmic domain con-
cluster of three consecutive charged residues (KEK94) to
taining mutations of leucine codons 413 and 414 to ala-
alanines reduced CD4 downregulation activity by 54%.
nines (CD884LL414AA), was also included. This protein is Mutation of arginines 105 and 106 also reduced Nef ac-
not downregulated by Nef (Aiken et al., 1994) and allowed
tivity by a similar amount. The second arginine in this
us to distinguish transfected from untransfected cells.
sequence has recently been shown to be critical for Nef’s
Surface levels of CD4 and CD884LL414AA were measured ability to associate with a protein serine kinase (Sawai
2 days after transfection by flow cytometry using CD4-
et al., 1995). Mutation of two Asp residues at 108 and
and CD8-specific antibodies, and the data were repre-
111 to alanines, as well as three charged residues at
sented as two-dimensional contour plots. The activity of
positions 177 to 179, destabilized the proteins, and no
each mutant nef allele was then calculated as a percent-
activity was detected in assays of these mutant alleles.
age of wild-type Nef activity as described under Materi-
These residues lie in a highly conserved region of Nef
als in Methods. An example of the assay results is shown
and may be required for its proper folding (Shugars et
in Fig. 3. Here we observed an 11-fold downregulation
al., 1993). Alteration of the conserved cysteine at position
of CD4 by wild-type Nef. The (Pxx)04 mutant, by compari- 142 resulted in a protein which retained only 4% of CD4
son, was 42% as active as wild-type Nef in this experi-
downregulation activity relative to wild-type Nef; how-
ment.
ever, this protein was unstable and accumulated only to
low levels in our assays (Fig. 2A, lane 11). This result isCD4 downregulation by Nef point mutants
consistent with a previous report that the identical muta-
tion in a hybrid HXB2 virus carrying the nef gene of theThe results of assays of CD4 downregulation by the
various Nef point mutants are depicted in Fig. 4. Because HIV-1 Eli isolate also rendered Nef unstable (Zazopoulos
and Hazeltine, 1992). Mutation of Glu154 and Glu155 tothe measurements were somewhat variable, we have
reported the mean values and standard deviations calcu- glutamines reduced Nef activity by three-fourths, while
alteration of Lys158 and Glu160 gave a protein whichlated from a minimum of three independent determina-
tions. In general, the larger uncertainties were associ- was 40% as active at downregulating CD4. However, the
CD4 downregulation assays of this mutant were ex-ated with the more active Nef alleles. Therefore, we con-
sider alleles with values exceeding that of the wild-type tremely variable, giving rise to a standard deviation
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FIG. 3. Rapid assay for CD4 downregulation by Nef. 293 cells were transfected with 10 mg of both CMX-CD4 and CMX-884DLL, and 20 mg Nef
expression plasmids or control vector. Cell-surface CD4 and CD8 levels were determined 2 days later by two-color flow cytometry and two-
dimensional contour plots prepared on a Sun workstation using Sundisplay 3. Quadrants were drawn as described under Materials and Methods,
and the number of cells in each quadrant was determined. CD4 downregulation by Nef is calculated as the ratio of the number of CD40/CD4/
cells in the rightmost two quadrants of each profile.
equivalent to that of the mean measurement itself. This feature of primary nef alleles (Mariani and Skowronski,
1993). Mutation of charged residues in the last 10 aminoresult may be related to the temperature-sensitive activity
of this allele, as discussed below. Mutation of the two acids (RE197AA and E201A/K204A) had relatively minor ef-
fects on CD4 downregulation by Nef. Surprisingly, theconserved aspartic acid residues at positions 174 and
175 to alanines gave rise to the only fully stable Nef latter protein was weakly detected in Western blots, even
though it was fairly active. Pulse–chase assays demon-mutant which was completely inactive. These residues
may interact with a cellular protein involved in mediating strated that this mutant protein was synthesized and was
similar in stability to the wild-type protein (Fig. 2B), sug-Nef activity or may be involved in the proper folding or
intracellular localization of Nef. The presence of acidic gesting that our antiserum failed to efficiently detect the
mutant protein in Western blots. It was previously re-amino acid codons at these positions is a nearly invariant
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notype of this protein at 377 may have contributed to the
high variability of CD4 downregulation assays of this al-
lele. Interestingly, we observed little, if any, reduction in
the stability of the K158A/E160G Nef protein at 37 and 397
relative to wild-type Nef (Fig. 5B). This suggests that the
temperature-sensitive activity of this mutant is due to
causes other than protein instability.
DISCUSSION
We have examined the effects of amino acid substitu-
tions and deletions on the ability of HIV-1 Nef to induce
CD4 downregulation. Charged residues were first tar-
geted in an attempt to minimize the risk of creating pro-
teins which were unstable or improperly folded. Highly
conserved sequence motifs, including two conserved
FIG. 4. Analysis of nef point mutants for CD4 downregulation activity.
CD4 downregulation assays were performed by transient transfection
in 293 cells followed by FACS analysis as described in the legend to
Fig. 3. Values shown are the mean of at least three independent assays
and are expressed as a percentage of wild-type Nef activity. Error bars
represent 1 standard deviation from the mean.
ported that a Nef protein truncated at amino acid 198 is
stable and active for CD4 downregulation, suggesting
that residues 198–206 are not required for Nef stability
or activity (Goldsmith et al., 1995).
Temperature sensitivity of CD4 downregulation by
Nef mutants
We tested mutant Nef alleles that were poorly active
for their temperature dependence of CD4 downregula-
tion. CD4 downregulation assays were performed as de-
scribed (Materials and Methods), with the exception that
one set of cultures was maintained at 327 for 3 days prior
to surface CD4 analysis by flow cytometry. Due to the
reduced cell growth rate at 327, an extended incubation
was found to result in optimal expression of the
transfected plasmids. The activity of wild-type Nef was
not significantly different at 32 vs 377 (data not shown).
Two altered Nef proteins were found to exhibit a temper-
ature-dependent ability to downregulate CD4. The Nef
protein containing the C142A mutation was only 4% active
at 377 but retained approximately 40% of wild-type Nef
activity when tested at 327 (Fig. 5A). Pulse–chase assays
of this mutant at 327 demonstrated a significant stabiliza-
FIG. 5. Temperature-dependent CD4 downregulation by mutant neftion of the protein when produced at this temperature
alleles. (A) Results of assays of CD4 downregulation by NefC142A and
(Fig. 5B). Assays of HIV-1 infectivity enhancement also NefK158A/E160A at various temperatures. Assays were performed by
revealed a temperature-dependent activity of this nef al- incubating 293 cells at the indicated temperatures after transfection
and analyzing surface CD4 expression by flow cytometry. (B) Pulse–lele (data not shown). The CD4 downregulation activity
chase analyses of the temperature dependence of mutant Nef stability.of the K158A/E160G Nef protein was 92% of wild-type Nef
Transfected 293 cells were pulse-labeled for 30 min with Tran35S-Labelat 327. This decreased to 40% at 377 and was 15% of
at 377. After removal of the labeling medium, cells were cultured at the
wild-type when tested at 397 (Fig. 5A). Thus, this protein 32, 37, or 397 and portions of the cultures were harvested at the indi-
exhibited a broader range of temperature dependence cated times. Radiolabeled Nef proteins were analyzed by immunopre-
cipitation using rabbit anti-Nef serum.than did NefC142A . The strong temperature-sensitive phe-
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cysteine residues, the proline-rich (Pxx)4 motif, and a po- for one, but not the other, of Nef’s activities. Preliminary
results in our laboratory suggest that there may be atential protein kinase C target (Thr80), were also mutated.
The various mutants were then tested for their ability to large amount of overlap in the sequence requirements
for CD4 downregulation and enhancement of viral infec-downregulate surface CD4 expression using a transient
transfection assay system. In general, mutations in tivity by HIV-1 Nef (C. Aiken, L. Krause, and D. Trono,
unpublished observations).charged residues in the carboxyl-terminal half of the pro-
tein had more deleterious effects than those in the Nef has been shown to be required for efficient SIV
replication and induction of AIDS in rhesus monkeysamino-terminal half. Charged residues which were ob-
served to be important for Nef function included Arg25 (Kestler et al., 1991), and nef-defective HIV-1 also exhib-
ited a reduced replication and pathology in the SCID/and Asp36, glutamates 154 and 155, and aspartates 174
and 175. Mutation of the latter two residues to alanines hu mouse model (Jamieson et al., 1994). The ability to
downregulate cell-surface CD4 expression is a commoneliminated Nef activity without affecting the stability of
the protein. This represented the only Nef point mutant property of primary alleles of HIV-1 nef (Mariani and Sko-
wronski, 1993), and we have observed that most primaryin our screen which was stable but was completely inac-
tive. Asp residues 108 and 111 were required for Nef alleles also enhance HIV-1 infectivity (Aiken and Trono,
1995). Is CD4 downregulation by Nef required for virusstability, and the nef allele encoding alanines at these
positions exhibited no activity. The same was observed replication and pathogenesis in vivo? Answering this
question will require viruses containing alleles of neffor simultaneous mutation of Glu177, Arg178, and Glu179
to alanines. A Nef protein with alanines substituted for capable of enhancing virus infectivity but unable to down-
regulate CD4.both Arg105 and Arg106 retained approximately one-half
of wild-type Nef activity. These residues are required for
Nef to associate with a cellular protein serine kinase ACKNOWLEDGMENTS
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